Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large trials of psychosocial interventions: examples from individual placement and support.

International journal of public health·2026
Same author

Predictors of competitive employment among people offered individual placement and support supported employment.

Psychiatric rehabilitation journal·2026
Same author

Feasibility and preliminary effectiveness of the Individual Placement and Support (IPS) model for people with serious mental illness in Jalisco, Mexico: a pilot study protocol.

Pilot and feasibility studies·2026
Same author

Using community engagement studios to involve persons living with dementia and their care partners in research design.

Journal of Alzheimer's disease : JAD·2026
Same author

Integrating Primary Care and Mental-Health Care: A Commentary on the Collaborative Care Model and the Psychiatry Consultation Clinic Model.

Administration and policy in mental health·2026
Same author

Individual Placement and Support and Long-Term Employment: A Review of Long-Term Follow-Up Studies.

Psychiatric services (Washington, D.C.)·2026
Same journal

Pharmacy of the Mind: The Uncanny Origins of Psychiatric Drugs, and The World That Shaped Them.

Journal of psychiatric practice·2026
Same journal

Commentary on the Risks of Prescription GLP-1 Agonists in Patients on Psychiatric Medications.

Journal of psychiatric practice·2026
Same journal

A Case of GLP-1 Receptor Agonist-Induced Lithium Neurotoxicity.

Journal of psychiatric practice·2026
Same journal

A Case of GLP-1 Receptor Agonist-Induced Dysphoria and Aggression in a Patient With Underlying Major Depressive Disorder.

Journal of psychiatric practice·2026
Same journal

Dispositional Mindfulness and Perceived Stress in Psychiatric and Nonpsychiatric Physicians: A Facet-level Pilot Study.

Journal of psychiatric practice·2026
Same journal

Prescribing Under Pressure: History and Legal Insights Into Boxed Warnings for Psychotropic Drugs.

Journal of psychiatric practice·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Shared decision making in antipsychotic management.

Lisa A Mistler1, Robert E Drake

  • 1Dartmouth Medical School, Hanover, NH, USA.

Journal of Psychiatric Practice
|December 6, 2008
PubMed
Summary
This summary is machine-generated.

Antipsychotic prescribing for schizophrenia can involve shared decision-making due to similar drug efficacies. Future integration of shared decision-making in antipsychotic prescribing can be enhanced by information technology.

Related Experiment Videos

Last Updated: Jun 27, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Area of Science:

  • Psychiatry
  • Pharmacology
  • Health Informatics

Background:

  • Current antipsychotic medications, excluding clozapine, demonstrate comparable efficacy, making them suitable for preference-sensitive care.
  • Shared decision-making (SDM) is a collaborative process between patients and clinicians, crucial for treatments where patient preferences significantly influence outcomes.
  • The integration of SDM in mental health, particularly in schizophrenia treatment, is an area of ongoing development.

Purpose of the Study:

  • To review the current landscape of antipsychotic prescribing for schizophrenia.
  • To evaluate the extent to which shared decision-making is currently incorporated into clinical practice and guidelines for antipsychotic prescribing.
  • To propose strategies for enhancing the use of SDM in future antipsychotic prescribing, leveraging information technology.

Main Methods:

  • A comprehensive literature review of recent landmark studies and updated prescribing guidelines related to schizophrenia treatment in the United States.
  • Analysis of current clinical practices and recommendations concerning the choice of antipsychotic medications.
  • Conceptual framework development for integrating SDM into the prescribing process.

Main Results:

  • The review indicates that current literature and guidelines for schizophrenia treatment in the U.S. do not strongly advocate for shared decision-making in antipsychotic prescribing.
  • Despite similar efficacies of available antipsychotics, the practice of SDM is not yet widely embedded in clinical protocols.
  • There is a recognized need and potential for improvement in patient involvement in treatment decisions.

Conclusions:

  • Shared decision-making is appropriate for antipsychotic prescribing due to the comparable effectiveness of available medications, excluding clozapine.
  • Current practices and guidelines show limited endorsement of SDM in schizophrenia treatment within the United States.
  • Implementing information technology can facilitate and enhance the integration of shared decision-making into future antipsychotic prescribing, improving patient-centered care.